176 results

• Overtreatment of Diabetic Nursing Home Residents Resulting in Hypoglycemia: Study

  March 29, 2022

  Randy Dixon, Jr.

  A new study reveals rampant overtreatment of nursing home residents with type 2 diabetes is resulting in patients with dangerously low blood sugar levels.

• Diabetes Drug Lawsuits Over Pancreatic Cancer Risk Dismissed, Again

  March 17, 2021

  Irvin Jackson

  A federal judge has again dismissed hundreds of diabetes drug lawsuits alleging medications like Byetta and Januvia can cause pancreatic cancer.

• Study Finds No Link Between Bone Fractures And Invokana, Similar Diabetes Drugs

  September 22, 2020

  Irvin Jackson

  A new study raises questions about FDA findings that Invokana and similar diabetes drugs can increase the risk of bone fractures.

• Diabetic Ketoacidosis Risk Tripled Among Users of Invokana, Similar Diabetes Drugs: Study

  August 5, 2020

  Irvin Jackson

  A new study appears to confirm FDA warnings that Invokana and similar diabetes drugs increase the risk of diabetic ketoacidosis in type 2 diabetes patients.

• Invokana, Farxiga and Similar Drugs Need Stronger Ketoacidosis Warnings for Type 1 Diabetics: Public Citizen

  July 7, 2020

  Irvin Jackson

  Public Citizen has petitioned the FDA to add black box warnings to Invokana and similar drugs, contraindicating their use by Type 1 diabetics due to the risk of diabetic ketoacidosis.

• Side Effects of Onglyza, Similar Diabetes Drugs More Likely To Cause Kidney Damage Than SGLT2 Inhibitors: Study

  May 11, 2020

  Irvin Jackson

  A new study finds that diabetes drugs like Invokana are less likely to cause kidney problems than drugs like Onglyza and Januvia.

• Study Suggests Acute Kidney Injury Warning for Invokana and Similar Diabetes Drugs Was Unwarranted

  April 9, 2020

  Irvin Jackson

  A new study questions the decision of the FDA to place acute kidney injury warnings on Invokana and similar diabetes drugs.

• FDA Issues Draft Guidance On Conducting Safety Trials For New Diabetes Drugs

  March 12, 2020

  Russell Maas

  A draft guidance seeks to require broader clinical trials for diabetes drugs, in an effort to better identify potential adverse health effects before they receive FDA approval.

• Pancreatic Cancer Lawsuits Over Byetta, Victoza and Other Diabetes Drugs Won’t Be Selected For Bellwether Trials Until Late 2020

  December 30, 2019

  Irvin Jackson

  The first bellwether trials for reinstated Byetta, Victoza, pancreatitis lawsuits are not likely to begin before late 2020.

• Side Effects of DiaBeta, Micronase, Similar Diabetes Drugs Carry Higher Risk Of Heart Problems Than Metformin: Study

  October 3, 2019

  Martha Garcia

  A new study finds there is a significantly increased risk of heart problems with drugs like DiaBeta and Micronase, compared to metformin, when patients have kidney function problems.